Aquaglyceroporins in Human Breast Cancer.
AQP
aquaglyceroporin
aquaporin
breast cancer
metastasis
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
31 08 2023
31 08 2023
Historique:
received:
27
06
2023
revised:
24
08
2023
accepted:
28
08
2023
medline:
11
9
2023
pubmed:
8
9
2023
entrez:
8
9
2023
Statut:
epublish
Résumé
Aquaporins are water channels that facilitate passive water transport across cellular membranes following an osmotic gradient and are essential in the regulation of body water homeostasis. Several aquaporins are overexpressed in breast cancer, and AQP1, AQP3 and AQP5 have been linked to spread to lymph nodes and poor prognosis. The subgroup aquaglyceroporins also facilitate the transport of glycerol and are thus involved in cellular metabolism. Transcriptomic analysis revealed that the three aquaglyceroporins, AQP3, AQP7 and AQP9, but not AQP10, are overexpressed in human breast cancer. It is, however, unknown if they are all expressed in the same cells or have a heterogeneous expression pattern. To investigate this, we employed immunohistochemical analysis of serial sections from human invasive ductal and lobular breast cancers. We found that AQP3, AQP7 and AQP9 are homogeneously expressed in almost all cells in both premalignant in situ lesions and invasive lesions. Thus, potential intervention strategies targeting cellular metabolism via the aquaglyceroporins should consider all three expressed aquaglyceroporins, namely AQP3, AQP7 and AQP9.
Identifiants
pubmed: 37681917
pii: cells12172185
doi: 10.3390/cells12172185
pmc: PMC10486483
pii:
doi:
Substances chimiques
Aquaglyceroporins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15681-6
pubmed: 20724658
Nat Commun. 2018 Nov 12;9(1):4749
pubmed: 30420639
Sci Rep. 2017 Dec 4;7(1):16878
pubmed: 29203879
J Clin Invest. 2011 Oct;121(10):3786-8
pubmed: 21965334
Am J Physiol Cell Physiol. 2023 Jul 1;325(1):C208-C223
pubmed: 37246634
Int J Mol Sci. 2017 Oct 27;18(11):
pubmed: 29077056
Nat Commun. 2023 Feb 3;14(1):600
pubmed: 36737436
Science. 1994 Apr 1;264(5155):92-5
pubmed: 8140421
Cell. 2023 Apr 13;186(8):1708-1728
pubmed: 36931265
J Clin Invest. 1995 Apr;95(4):1838-45
pubmed: 7535800
Clin Med Insights Pathol. 2015 Dec 21;8:23-31
pubmed: 26740749
Sci Bull (Beijing). 2021 Aug 15;66(15):1550-1558
pubmed: 36654284
Sci Transl Med. 2020 Oct 7;12(564):
pubmed: 33028705
Cancer Res. 2020 Oct 1;80(19):4071-4086
pubmed: 32631905
Oncotarget. 2016 Feb 16;7(7):8143-54
pubmed: 26812884
Glia. 2007 Aug 1;55(10):1034-43
pubmed: 17549682
Am J Physiol Cell Physiol. 2023 Feb 1;324(2):C307-C319
pubmed: 36468842
Int J Mol Sci. 2017 Jan 29;18(2):
pubmed: 28146084
Proc Natl Acad Sci U S A. 1997 May 13;94(10):5450-5
pubmed: 9144258
Acta Diabetol. 2012 Dec;49 Suppl 1:S215-26
pubmed: 23001483
J Biol Chem. 2007 Jan 12;282(2):1183-92
pubmed: 17105724
Pflugers Arch. 2008 Jul;456(4):693-700
pubmed: 17968585
Oncol Lett. 2018 Aug;16(2):2661-2667
pubmed: 30013662
Int J Mol Med. 2018 Sep;42(3):1548-1558
pubmed: 29901079
Redox Biol. 2020 Jan;28:101326
pubmed: 31546170
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Mol Med Rep. 2015 Apr;11(4):2882-8
pubmed: 25515250
Nat Rev Nephrol. 2023 Sep;19(9):604-618
pubmed: 37460759
J Histochem Cytochem. 2016 May;64(5):287-300
pubmed: 27026296
J Clin Invest. 1997 Apr 1;99(7):1500-5
pubmed: 9119993
Biochem Biophys Res Commun. 2000 Oct 5;276(3):1118-28
pubmed: 11027599
APMIS. 2022 May;130(5):253-260
pubmed: 35114014
Cancers (Basel). 2020 Jul 15;12(7):
pubmed: 32679804
Mol Cell Biol. 2007 Sep;27(17):6026-37
pubmed: 17576812
Cells. 2022 Jun 10;11(12):
pubmed: 35741021
Ann Surg Oncol. 2014 Feb;21(2):375-83
pubmed: 24114055
Biochem Biophys Res Commun. 2023 Jan 8;639:126-133
pubmed: 36481356
Am J Physiol Cell Physiol. 2021 Mar 1;320(3):C282-C292
pubmed: 33175575
J Exp Clin Cancer Res. 2011 Sep 25;30:86
pubmed: 21943213
Cancers (Basel). 2019 Jul 03;11(7):
pubmed: 31277235
Mol Cell Biol. 2008 Jan;28(1):326-32
pubmed: 17967887
Antioxid Redox Signal. 2013 Nov 1;19(13):1447-51
pubmed: 23541115
APMIS. 2021 Dec;129(12):700-705
pubmed: 34582595
Cancer Med. 2020 Jun;9(11):3904-3917
pubmed: 32253832
FASEB J. 2019 Jun;33(6):6980-6994
pubmed: 30840830
APMIS. 2022 Jan;130(1):3-10
pubmed: 34758159
Biochem Biophys Res Commun. 2016 Feb 26;471(1):191-7
pubmed: 26837049
J Mol Histol. 2005 Feb;36(1-2):1-14
pubmed: 15703994
Cancer Manag Res. 2019 Feb 14;11:1503-1515
pubmed: 30863160
PLoS One. 2011;6(12):e28492
pubmed: 22145049
Biochem Biophys Res Commun. 2017 Nov 25;493(3):1210-1216
pubmed: 28958942
Int J Mol Sci. 2017 Oct 07;18(10):
pubmed: 28991174
Am J Physiol Cell Physiol. 2021 May 1;320(5):C771-C777
pubmed: 33625928
Int J Biochem Cell Biol. 2016 Oct;79:271-276
pubmed: 27609140
Biochim Biophys Acta Biomembr. 2020 Feb 1;1862(2):183065
pubmed: 31521632